Filter Results:
(1,327)
Show Results For
- All HBS Web
(1,327)
- People (2)
- News (344)
- Research (765)
- Events (2)
- Multimedia (5)
- Faculty Publications (392)
Show Results For
- All HBS Web
(1,327)
- People (2)
- News (344)
- Research (765)
- Events (2)
- Multimedia (5)
- Faculty Publications (392)
- January 2003 (Revised May 2003)
- Case
AngloGold - Corporate Responsibility for HIV/AIDS (A)
AngloGold, a South African gold-mining corporation, faces a decision to provide its workforce, 30% of which is infected with HIV, with antiretroviral treatment. View Details
Keywords: Health Disorders; Corporate Social Responsibility and Impact; Employees; Mining Industry; South Africa
Barrett, Diana, and Amanda Key. "AngloGold - Corporate Responsibility for HIV/AIDS (A)." Harvard Business School Case 303-101, January 2003. (Revised May 2003.)
- October 2022 (Revised September 2024)
- Case
mPharma: Scaling Access to Affordable Primary Care in Africa
By: Regina E. Herzlinger and Ben Creo
mPharma hopes to scale up to create the largest pan-African healthcare company ever to provide much-needed primary care in retail pharmacies; a reliable, fairly priced supply of drugs; and micro-insurance for drugs. They must prioritize launching a telemedicine... View Details
Keywords: Africa; Pharmaceutical Companies; Pharmacy Benefit Manager; Health Care; Health Care And Treatment; Health Care Costs; Health Care Delivery; Health Care Entrepreneurship; Telehealth; Health Equity; Corporate Strategy; Social Entrepreneurship; Equity; Growth and Development Strategy; Expansion; Product Launch; Customer Value and Value Chain; Social Enterprise; Multinational Firms and Management; Health Industry; Health Industry; Africa
Herzlinger, Regina E., and Ben Creo. "mPharma: Scaling Access to Affordable Primary Care in Africa." Harvard Business School Case 323-033, October 2022. (Revised September 2024.)
- 26 Mar 2020
- News
Coronavirus Is Widening the Corporate Digital Divide
- May 2012 (Revised August 2014)
- Case
McKesson
By: Regina E. Herzlinger and Natalie Kindred
McKesson, a large, diversified drug distribution and health care IT company, is considering development of new business offerings to help private practice physicians remain independent. The company, with $122 billion in 2010 revenues, just made its first foray into... View Details
Keywords: Health Care Industry; Health Care Policy; Organizational Transformations; Health Services; Health Care and Treatment; Business Model; Service Operations; Change Management; Corporate Strategy; Information Technology; Policy; Health Industry; Health Industry; United States
Herzlinger, Regina E., and Natalie Kindred. "McKesson." Harvard Business School Case 312-002, May 2012. (Revised August 2014.)
- 01 Feb 1997
- News
Ban the Butterfly Rule for Corporate Directors
You're only as good as your job title? Apparently so, if you're the director of a major company. A corporate governance precept currently in vogue calls for outside directors to offer to resign if they change (or lose) their jobs.... View Details
Keywords: Joseph Hinsey IV
- 18 Sep 2014
- News
The shortcomings of the corporate wellness program
- 14 Oct 2002
- Research & Ideas
The Widening Rift Between Corporations and Society
Society is evolving and it is leaving business behind, say HBS professor Shoshana Zuboff and James Maxmin. In their new book, The Support Economy: Why Corporations are Failing Individuals and the Next Episode of Capitalism, they address... View Details
Keywords: by Martha Lagace
- 31 Oct 2013
- News
Have corporate and government leaders lost accountability?
- August 2023
- Case
Constellation Pharmaceuticals: Corporate Development at a Novel Therapeutic Company
By: Satish Tadikonda and Brad Prosek
Constellation Pharmaceuticals was a company focused on epigenetic therapies for cancer patients. Despite a promising start and an early deal with a leading biopharma company, the company weathered twin setbacks in the end of a major research collaboration and the... View Details
Keywords: Mergers and Acquisitions; Health Care and Treatment; Organizational Change and Adaptation; Research and Development; Business Strategy; Partners and Partnerships; Goals and Objectives; Pharmaceutical Industry; United States
Tadikonda, Satish, and Brad Prosek. "Constellation Pharmaceuticals: Corporate Development at a Novel Therapeutic Company." Harvard Business School Case 824-032, August 2023.
- August 2008
- Teaching Note
Go Red for Women: Raising Heart Health Awareness (TN)
By: V. Kasturi Rangan and Marie Madelene Bell
Teaching Note for [507026]. View Details
- Web
Creating Value Through Corporate Restructuring - Course Catalog
financing, mass tort clais, restructuring of retiree health care/pension plans, and corporate layoff/downsizing programs. While the course focuses on U.S. corporates, it also applies the core principles of... View Details
- June 2024 (Revised December 2024)
- Case
Lana Ghanem: Pushing the Boundaries of Health Care Through Venture Capital
By: Joshua D. Margolis and Ahmed Dahawy
Lana Ghanem, managing director of Hikma Ventures, the corporate venture arm of larger pharmaceutical group Hikma, is considering how to grow the venture arm as well as progress her own career. Over the past few years Hikma's executive team had been pressuring the... View Details
Keywords: Business Divisions; Corporate Entrepreneurship; Investment; Corporate Governance; Health Care and Treatment; Leadership Development; Business or Company Management; Growth and Development Strategy; Business Strategy; Venture Capital; Personal Development and Career; Health Industry; Health Industry; Jordan
Margolis, Joshua D., and Ahmed Dahawy. "Lana Ghanem: Pushing the Boundaries of Health Care Through Venture Capital." Harvard Business School Case 424-075, June 2024. (Revised December 2024.)
- Fall 2020
- Article
Sizing Up Corporate Restructuring in the COVID Crisis
By: Robin Greenwood, Benjamin Iverson and David Thesmar
In the wake of the COVID-19 pandemic, the financial and legal system will need to deal with a surge of financial distress in the business sector. Some firms will be able to survive, while others will face bankruptcy and thus need to be liquidated or reorganized. Many... View Details
Greenwood, Robin, Benjamin Iverson, and David Thesmar. "Sizing Up Corporate Restructuring in the COVID Crisis." Brookings Papers on Economic Activity (Fall 2020). (Also NBER Working Paper, No. 28104.)
- Web
Leadership, Ethics, and Corporate Accountability Course | HBS Online
Heritage Health Read more learner stories * Source: 2022 surveys and course data All FAQs Leadership, Ethics, and Corporate Accountability FAQs What are the learning requirements, and how are grades... View Details
- 01 Apr 2020
- News
Coronavirus Is Putting Corporate Social Responsibility to the Test
- Web
Women, Work, and the “M” Word - Blog: Health Supplement
Blog Blog Health Care and Life Science at HBS Filter Results Arrow Down Arrow Up Read posts from Author Alumni Author Blavatnik Fellow Author Blavatnik Fellowship Team Author Executive Education Author HBS Partners Author HBS Staff Author... View Details
- 17 Feb 2016
- Blog Post
Through The Eyes of The Patient: A Recap of The 13th Annual Health Care Conference
markets, to changing the drug discovery process to be more patient-centric. A highlight of the panel sessions was when Adam Koppel, EVP of Strategy and Corporate Development at Biogen and Health Care... View Details
Keywords: Health Care
- March 1999
- Case
Merck & Co., Inc.: Corporate Strategy, Organization and Culture (A)
By: Michael Beer and Perry Fagan
In the early 1990s, Merck faced a series of challenges because of significant changes in its competitive and regulatory environment (e.g., growth in power of pharmaceutical buyers like managed care organizations led to price pressures and President Clinton's review of... View Details
Keywords: Organizational Change and Adaptation; Business or Company Management; Organizational Culture; Problems and Challenges; Management Practices and Processes; Competitive Strategy; Management Teams; Health Care and Treatment; Governing Rules, Regulations, and Reforms; Situation or Environment; Alignment; Pharmaceutical Industry; United States
Beer, Michael, and Perry Fagan. "Merck & Co., Inc.: Corporate Strategy, Organization and Culture (A)." Harvard Business School Case 499-054, March 1999.
- 06 May 2019
- Research & Ideas
Consumers Blame Business for Global Health Problems. Can Business Become the Solution?
long used corporate social responsibility initiatives and philanthropy to improve their standing with consumers. Now there is a new crop of companies that are making health and wellness a business... View Details